合成生物与生物制造 · 全部实体（第 18 / 100 页）

本页收录第 1701–1800 条，共 10000 条 · 返回 合成生物与生物制造 首页

• Porous chitin powder decorated with ZIF-8-derived nanozyme for diabetic infected wound healing.
  europepmc 2025 置信度 0.80
• Efficient fermentative production of SAM through multidimensional engineering of Saccharomyces cerevisiae.
  europepmc 2025 置信度 0.80
• Self-assembled enzyme biosensors based on xanthine oxidase (XO) and CS@GO for screening natural products for anti-gout active ingredients.
  europepmc 2025 置信度 0.80
• GABA-Producing Levilactobacillus brevis LAB6 Mitigates Pentylenetetrazol-Induced Gut-Brain Dysregulation in SD Rats.
  europepmc 2025 置信度 0.80
• Integrated Protein Engineering and Expression Balancing Enable Efficient d-Allulose Production.
  europepmc 2025 置信度 0.80
• Revolutionizing lignin valorization: Key advances in demethylation, methylation, and methyl metabolism.
  europepmc 2025 置信度 0.80
• Exploring protein-mediated quality control mechanisms in Rice cooking behavior: from static protein content to dynamic architecture.
  europepmc 2025 置信度 0.80
• Correction: Streamlined protoplast transfection system for in-vivo validation and transgene-free genome editing in Banana.
  europepmc 2025 置信度 0.80
• Versatile and tunable dual-layer signal amplifier enables ultrasensitive cellular sensors for chemicals.
  europepmc 2025 置信度 0.80
• High-yield enzymatic synthesis of UDP-β-L-arabinose via a novel two-enzyme cascade: Structure insights into arabinokinase and engineered UDP-sugar pyrophosphorylase.
  europepmc 2025 置信度 0.80
• Engineering MtrAB two-component system enhances protein and glutamate export in corynebacterium glutamicum through cell wall remodeling.
  europepmc 2025 置信度 0.80
• Relationships of cereal β-glucan structural and physicochemical characteristics with Lactobacillus plantarum encapsulation and viability in alginate-based microgels.
  europepmc 2025 置信度 0.80
• On-orbit 3D bioprinting for tumor modeling in space.
  europepmc 2025 置信度 0.80
• [Intelligent design of nucleic acid elements in biomanufacturing].
  europepmc 2025 置信度 0.80
• The wheat VIH2-3B, a functional PPIP5K controls the localization of fasciclin-like arabinogalactan protein.
  europepmc 2025 置信度 0.80
• AI-driven de novo enzyme design: Strategies, applications, and future prospects.
  europepmc 2025 置信度 0.80
• Investigation of in vitro delivery conditions for self-amplifying mRNA.
  europepmc 2025 置信度 0.80
• High-efficiency chemiluminescent POCT assay for anti-Müllerian hormone: innovative development and application in polycystic ovary syndrome diagnosis.
  europepmc 2025 置信度 0.80
• [Databases, knowledge bases, and large models for biomanufacturing].
  europepmc 2025 置信度 0.80
• A superior lipase for cheese production: A precisely medium-chain selective lipase from Pleurotus citrinopileatus expressed in Pichia pastoris.
  europepmc 2025 置信度 0.80
• Engineering Glycosyltransferase by Semi-Rational Design for Highly Regioselective Synthesis of Polydatin.
  europepmc 2025 置信度 0.80
• Yeast species resource exploration and application in cell factories.
  europepmc 2026 置信度 0.80
• Self-healing, degradable, and implantable tissue-like sensor for monitoring of abnormal bladder activity.
  europepmc 2025 置信度 0.80
• Scaffolding Strategies in Mimicking Muscle and Fat Tissue: Focus on the Current Primary Challenge in Cultured Meat.
  europepmc 2025 置信度 0.80
• A neuraminidase-based electrochemical biosensor for high-throughput screening of antiviral compounds in traditional Chinese medicine.
  europepmc 2025 置信度 0.80
• Crystal structure and inhibition mechanism of AcrIIA11.
  europepmc 2025 置信度 0.80
• Systematic engineering of the sterol synthesis pathway for Saccharomyces cerevisiae promotes the efficient production of β-caryophyllene.
  europepmc 2025 置信度 0.80
• pH-triggered small molecule theranostic nanodrug mediates selective tumor CT imaging and chemotherapy.
  europepmc 2025 置信度 0.80
• Chromosomal Integration of budAB Operons and Pathway Rewiring Enhance Acetoin Production From Starch in Vibrio diabolicus.
  europepmc 2025 置信度 0.80
• Recommended nomenclature convention for the NISTCHO cell line and its product monoclonal antibody, cNISTmAb.
  europepmc Megan H. Cleveland, Ioannis L. Karageorgos, John P. Marino, Michael J. Tarlov 等 2025 置信度 0.80
• Complete genome and QbD-guided reverse vaccinology for Streptococcus iniae strain SIKU01
  🧬 Whole Genome Assembly of 5 Streptococcus iniae bacteria isolated from diseased Asian Seabass, Thailand, comparative genomics, validation of WGS and in-sillico identification of antigens for vaccine biomanufacturing via Quality by Design (QbD). Organism: Str…
  datacite ANDRES, Quentin Ludovic Stephane, Uchuwittayakul, Anurak, Srisapoome, Prapansak 2025 置信度 0.66
• Complete genome and QbD-guided reverse vaccinology for Streptococcus iniae strain SIKU01
  🧬 Whole Genome Assembly of 5 Streptococcus iniae bacteria isolated from diseased Asian Seabass, Thailand, comparative genomics, validation of WGS and in-sillico identification of antigens for vaccine biomanufacturing via Quality by Design (QbD). Organism: Str…
  datacite ANDRES, Quentin Ludovic Stephane, Uchuwittayakul, Anurak, Srisapoome, Prapansak 2025 置信度 0.66
• IA & Biotechnologies Multi-omiques pour la Santé, la Longévité et la Bioproduction
  Abstract ENThis document, produced with the assistance of ChatGPT o3 and GPT-5 Thinking, is released under the Apache 2.0 licence. It is a voluntary defensive publication (prior art) and therefore enters the prior art upon release under the applicable patent s…
  datacite Pillet, Xavier 2025 置信度 0.66
• IA & Biotechnologies Multi-omiques pour la Santé, la Longévité et la Bioproduction
  Abstract ENThis document, produced with the assistance of ChatGPT o3 and GPT-5 Thinking, is released under the Apache 2.0 licence. It is a voluntary defensive publication (prior art) and therefore enters the prior art upon release under the applicable patent s…
  datacite Pillet, Xavier 2025 置信度 0.66
• IA & Biotechnologies Multi-omiques pour la Santé, la Longévité et la Bioproduction
  Abstract ENThis document, produced with the assistance of ChatGPT o3 and GPT-5 Thinking, is released under the Apache 2.0 licence. It is a voluntary defensive publication (prior art) and therefore enters the prior art upon release under the applicable patent s…
  datacite Pillet, Xavier 2025 置信度 0.66
• MassIVE MSV000098934 - Metabolomics Dataset accompanying "Microgravity-Induced Constraints on Melanin Bioproduction: Investigating E. coli Metabolic Responses Aboard the International Space Station (ISS)"
  datacite J Hervey 2025 置信度 0.66
• Development of a Universal Influenza Vaccine via the Hamzah Model.
  All Articles are Available: Orcid ID: https://orcid.org/my-orcid?orcid=0009-0009-3175-8563 Science Open ID: https://www.scienceopen.com/user/2c98a8bc-b8bb-49b3-9c91-2f2986a7e16e Safe Creative register the work titled "The Theory of Intelligent Evolution, the H…
  datacite JALALI, SEYED RASOUL 2025 置信度 0.66 ψ–Hamzah Equation, universal influenza vaccine, Seyed Rasoul Jalali, fractional calculus, fractal memory, fractal–fractional derivatives, universal vaccine, pandemic prevention, nanomedicine, vaccine design, RNA vaccine, recombinant antigens, antigenic drift, antigenic shift, influenza virus, H1N1, H3N2, H5N1, hemagglutinin, neuraminidase, M2e protein, conserved epitopes, immunological memory, adaptive immunity, humoral response, cellular immunity, B-cell activation, T-cell stimulation, interferon gamma, IL-12, cytokine regulation, immune modelling, stochastic modelling, Monte Carlo simulation, Sobol sequences, epidemiological modelling, viral mutation, drug resistance, genetic recombination, computational immunology, bioinformatics, nanotechnology, lipid nanoparticles, PEGylation, liposomes, PLGA polymers, controlled release, slow release vaccine, nano-adjuvant, quantum nanogold, fractal nanostructures, microfluidic mixing, sonication, lyophilisation, bioreactor production, HEK293 cells, recombinant protein production, high performance liquid chromatography, nanoparticle stability, DLS analysis, ELISA testing, sterility assay, thermal shift assay, vaccine stability, global health, WHO standards, pandemic resilience, universal immunotherapy, mathematical biology, nonlinear dynamics, stochastic differential equations, fractional integrals, memory kernels, Volterra equations, Riemann–Liouville derivative, Caputo derivative, fractal operators, operator theory, chaos theory, immuno-fractal dynamics, epidemiological forecasting, AI in immunology, machine learning vaccine design, gradient boosting immunology, PCA immune modelling, standard scaling, supervised classification, vaccine efficacy analysis, clinical trial modelling, vaccine safety, adverse reaction minimisation, immunotoxicology, biocompatibility, nanotoxicology, pharmacovigilance, in-vivo validation, in-vitro validation, in-silico modelling, translational medicine, computational pharmacology, systems immunology, quantitative immunology, mathematical epidemiology, pandemic forecasting, influenza eradication, universal health coverage, equity of access, ethical biomedicine, global vaccination, immunisation policy, vaccine deployment, low-resource settings, vaccine logistics, cold chain supply, decentralised vaccine production, modular vaccine factories, biosafety standards, biosafety level 3, biosafety level 4, industrial biomanufacturing, synthetic biology, molecular engineering, genetic engineering, epigenetic modelling, host-pathogen dynamics, host immunity, population immunity, herd immunity, threshold immunity, R0 reduction, vaccine adoption, vaccine hesitancy, societal impact, behavioural epidemiology, virology, structural virology, crystallography of HA, cryo-EM vaccine structure, computational protein design, epitope mapping, antibody binding, T-cell receptor mapping, peptide synthesis, multi-epitope vaccine, chimeric antigens, DNA vaccines, mRNA vaccines, protein subunit vaccines, vector-based vaccines, live attenuated vaccines, inactivated vaccines, synthetic vaccines, personalised vaccines, oncology vaccine, anti-cancer therapy, cancer immunotherapy, checkpoint inhibitors, tumour microenvironment, tumour immunology, T-cell exhaustion, PD-1 inhibitors, CTLA-4 inhibitors, vaccine-enhanced immunotherapy, dual-purpose vaccines, influenza–cancer synergy, immune checkpoint modulation, computational oncology, mathematical oncology, tumour dynamics, fractal tumour modelling, tumour angiogenesis, hypoxia modelling, metastasis modelling, oncogene targeting, gene therapy, CRISPR immunotherapy, immune editing, adaptive immune resilience, global virology, future pandemics, zoonotic diseases, cross-species transmission, avian influenza, swine influenza, bat influenza, viral reservoirs, climate change and influenza, ecological modelling, viral ecology, human mobility modelling, urban epidemiology, rural epidemiology, refugee health, vulnerable populations, immunocompromised patients, elderly populations, paediatric immunisation, maternal immunisation, cross-reactivity, epitope conservation, universal epitope targeting, cross-neutralisation, antibody titres, neutralisation assay, immunogenicity testing, vaccine potency assay, lot release testing, GMP manufacturing, ISO5 clean room, ISO7 preparation room, HEPA filtration, positive pressure rooms, microfluidics, nanoencapsulation, encapsulation efficiency, vaccine delivery, oral vaccines, injectable vaccines, intranasal vaccines, mucosal immunity, mucosal vaccines, IgA response, systemic immunity, systemic IgG, mucosal T-cells, trained immunity, innate memory, NK cells, dendritic cells, macrophages, neutrophils, immunometabolism, metabolic reprogramming, glycolysis, oxidative phosphorylation, immune exhaustion, immune senescence, rejuvenation of immunity, long-term protection, booster doses, universal schedule, clinical trial phase I, clinical trial phase II, clinical trial phase III, regulatory approval, EMA, FDA, MHRA, WHO prequalification, global distribution, vaccine economics, vaccine innovation, intellectual property, ethical vaccine development, scientific integrity, transparency in science, open science, global collaboration, AI in drug discovery, computational vaccinology, quantum biology, quantum pharmacology, hybrid bio-AI models, evolutionary modelling, phylogenetics, molecular phylogeny, influenza evolution, phylogenetic trees, phylogenetic fractals, fractal phylogeny, entropy modelling, Shannon entropy of viral genomes, information theory in virology, complex systems, multi-scale modelling, scaling laws, universality in biology, Hamzah universal model, ψ–Hamzah framework, ψ–Hamzah Equation, Jalali Hamzah equation, Hamzah anti-cancer vaccine, Hamzah anti-cancer medicine, cancer nanotherapy, vaccine nanotherapy, fractal therapeutics, quantum immune modulators, precision medicine, personalised immunology, stratified medicine, pharmacogenomics, pharmaco-epidemiology, bioethics, humanitarian vaccines, pandemic ethics, dual-use technology, biosafety governance, intellectual property declaration, scientific ownership, Rasoul Jalali declaration, Hamzah vaccine patent, universal vaccine declaration, ethical biomedical AI, equitable science, sustainable vaccines, global preparedness, one health approach, integrated immunology, mathematical physics in medicine, biomedical physics, computational complexity, trillion-scenario simulation, Monte Carlo trillion scenarios, Sobol sampling, uncertainty quantification, sensitivity analysis, variance decomposition, statistical robustness, reproducibility, robustness of vaccine, resilience of immune response, deterministic chaos in immunity, stochastic resilience, probabilistic immunity, epidemic control, mathematical control theory, optimal control vaccination, vaccination strategy, targeted vaccination, mass vaccination, ring vaccination, adaptive vaccination, dynamic dosing, dose optimisation, pharmacokinetics, pharmacodynamics, absorption, distribution, metabolism, excretion, drug clearance, biotransformation, immunopharmacology, nanopharmacology, toxicodynamics, vaccine-drug synergy, combination therapy, dual-use vaccines, future-proof vaccines, predictive vaccinology, anticipatory science, foresight in immunology, vaccine roadmaps, grand challenges, Hamzah paradigm, ψ–Hamzah universality, ψ–Hamzah declaration, ψ–Hamzah mathematics, ψ–Hamzah immunology, ψ–Hamzah pharmacology, ψ–Hamzah oncology, ψ–Hamzah virology, ψ–Hamzah nanomedicine, ψ–Hamzah bioinformatics, ψ–Hamzah AI modelling, ψ–Hamzah global health, ψ–Hamzah ethics, ψ–Hamzah intellectual property, ψ–Hamzah declaration 2025, Seyed Rasoul Jalali framework, Jalali scientific paradigm, Hamzah biophysics, Hamzah computational biology, Hamzah resilience, Hamzah immunodynamics, Hamzah adaptive fractals, Hamzah stochastic immunity, Hamzah pandemic preparedness, Hamzah biomedical revolution.
• Development of a Universal Influenza Vaccine via the Hamzah Model.
  All Articles are Available: Orcid ID: https://orcid.org/my-orcid?orcid=0009-0009-3175-8563 Science Open ID: https://www.scienceopen.com/user/2c98a8bc-b8bb-49b3-9c91-2f2986a7e16e Safe Creative register the work titled "The Theory of Intelligent Evolution, the H…
  datacite JALALI, SEYED RASOUL 2025 置信度 0.66 ψ–Hamzah Equation, universal influenza vaccine, Seyed Rasoul Jalali, fractional calculus, fractal memory, fractal–fractional derivatives, universal vaccine, pandemic prevention, nanomedicine, vaccine design, RNA vaccine, recombinant antigens, antigenic drift, antigenic shift, influenza virus, H1N1, H3N2, H5N1, hemagglutinin, neuraminidase, M2e protein, conserved epitopes, immunological memory, adaptive immunity, humoral response, cellular immunity, B-cell activation, T-cell stimulation, interferon gamma, IL-12, cytokine regulation, immune modelling, stochastic modelling, Monte Carlo simulation, Sobol sequences, epidemiological modelling, viral mutation, drug resistance, genetic recombination, computational immunology, bioinformatics, nanotechnology, lipid nanoparticles, PEGylation, liposomes, PLGA polymers, controlled release, slow release vaccine, nano-adjuvant, quantum nanogold, fractal nanostructures, microfluidic mixing, sonication, lyophilisation, bioreactor production, HEK293 cells, recombinant protein production, high performance liquid chromatography, nanoparticle stability, DLS analysis, ELISA testing, sterility assay, thermal shift assay, vaccine stability, global health, WHO standards, pandemic resilience, universal immunotherapy, mathematical biology, nonlinear dynamics, stochastic differential equations, fractional integrals, memory kernels, Volterra equations, Riemann–Liouville derivative, Caputo derivative, fractal operators, operator theory, chaos theory, immuno-fractal dynamics, epidemiological forecasting, AI in immunology, machine learning vaccine design, gradient boosting immunology, PCA immune modelling, standard scaling, supervised classification, vaccine efficacy analysis, clinical trial modelling, vaccine safety, adverse reaction minimisation, immunotoxicology, biocompatibility, nanotoxicology, pharmacovigilance, in-vivo validation, in-vitro validation, in-silico modelling, translational medicine, computational pharmacology, systems immunology, quantitative immunology, mathematical epidemiology, pandemic forecasting, influenza eradication, universal health coverage, equity of access, ethical biomedicine, global vaccination, immunisation policy, vaccine deployment, low-resource settings, vaccine logistics, cold chain supply, decentralised vaccine production, modular vaccine factories, biosafety standards, biosafety level 3, biosafety level 4, industrial biomanufacturing, synthetic biology, molecular engineering, genetic engineering, epigenetic modelling, host-pathogen dynamics, host immunity, population immunity, herd immunity, threshold immunity, R0 reduction, vaccine adoption, vaccine hesitancy, societal impact, behavioural epidemiology, virology, structural virology, crystallography of HA, cryo-EM vaccine structure, computational protein design, epitope mapping, antibody binding, T-cell receptor mapping, peptide synthesis, multi-epitope vaccine, chimeric antigens, DNA vaccines, mRNA vaccines, protein subunit vaccines, vector-based vaccines, live attenuated vaccines, inactivated vaccines, synthetic vaccines, personalised vaccines, oncology vaccine, anti-cancer therapy, cancer immunotherapy, checkpoint inhibitors, tumour microenvironment, tumour immunology, T-cell exhaustion, PD-1 inhibitors, CTLA-4 inhibitors, vaccine-enhanced immunotherapy, dual-purpose vaccines, influenza–cancer synergy, immune checkpoint modulation, computational oncology, mathematical oncology, tumour dynamics, fractal tumour modelling, tumour angiogenesis, hypoxia modelling, metastasis modelling, oncogene targeting, gene therapy, CRISPR immunotherapy, immune editing, adaptive immune resilience, global virology, future pandemics, zoonotic diseases, cross-species transmission, avian influenza, swine influenza, bat influenza, viral reservoirs, climate change and influenza, ecological modelling, viral ecology, human mobility modelling, urban epidemiology, rural epidemiology, refugee health, vulnerable populations, immunocompromised patients, elderly populations, paediatric immunisation, maternal immunisation, cross-reactivity, epitope conservation, universal epitope targeting, cross-neutralisation, antibody titres, neutralisation assay, immunogenicity testing, vaccine potency assay, lot release testing, GMP manufacturing, ISO5 clean room, ISO7 preparation room, HEPA filtration, positive pressure rooms, microfluidics, nanoencapsulation, encapsulation efficiency, vaccine delivery, oral vaccines, injectable vaccines, intranasal vaccines, mucosal immunity, mucosal vaccines, IgA response, systemic immunity, systemic IgG, mucosal T-cells, trained immunity, innate memory, NK cells, dendritic cells, macrophages, neutrophils, immunometabolism, metabolic reprogramming, glycolysis, oxidative phosphorylation, immune exhaustion, immune senescence, rejuvenation of immunity, long-term protection, booster doses, universal schedule, clinical trial phase I, clinical trial phase II, clinical trial phase III, regulatory approval, EMA, FDA, MHRA, WHO prequalification, global distribution, vaccine economics, vaccine innovation, intellectual property, ethical vaccine development, scientific integrity, transparency in science, open science, global collaboration, AI in drug discovery, computational vaccinology, quantum biology, quantum pharmacology, hybrid bio-AI models, evolutionary modelling, phylogenetics, molecular phylogeny, influenza evolution, phylogenetic trees, phylogenetic fractals, fractal phylogeny, entropy modelling, Shannon entropy of viral genomes, information theory in virology, complex systems, multi-scale modelling, scaling laws, universality in biology, Hamzah universal model, ψ–Hamzah framework, ψ–Hamzah Equation, Jalali Hamzah equation, Hamzah anti-cancer vaccine, Hamzah anti-cancer medicine, cancer nanotherapy, vaccine nanotherapy, fractal therapeutics, quantum immune modulators, precision medicine, personalised immunology, stratified medicine, pharmacogenomics, pharmaco-epidemiology, bioethics, humanitarian vaccines, pandemic ethics, dual-use technology, biosafety governance, intellectual property declaration, scientific ownership, Rasoul Jalali declaration, Hamzah vaccine patent, universal vaccine declaration, ethical biomedical AI, equitable science, sustainable vaccines, global preparedness, one health approach, integrated immunology, mathematical physics in medicine, biomedical physics, computational complexity, trillion-scenario simulation, Monte Carlo trillion scenarios, Sobol sampling, uncertainty quantification, sensitivity analysis, variance decomposition, statistical robustness, reproducibility, robustness of vaccine, resilience of immune response, deterministic chaos in immunity, stochastic resilience, probabilistic immunity, epidemic control, mathematical control theory, optimal control vaccination, vaccination strategy, targeted vaccination, mass vaccination, ring vaccination, adaptive vaccination, dynamic dosing, dose optimisation, pharmacokinetics, pharmacodynamics, absorption, distribution, metabolism, excretion, drug clearance, biotransformation, immunopharmacology, nanopharmacology, toxicodynamics, vaccine-drug synergy, combination therapy, dual-use vaccines, future-proof vaccines, predictive vaccinology, anticipatory science, foresight in immunology, vaccine roadmaps, grand challenges, Hamzah paradigm, ψ–Hamzah universality, ψ–Hamzah declaration, ψ–Hamzah mathematics, ψ–Hamzah immunology, ψ–Hamzah pharmacology, ψ–Hamzah oncology, ψ–Hamzah virology, ψ–Hamzah nanomedicine, ψ–Hamzah bioinformatics, ψ–Hamzah AI modelling, ψ–Hamzah global health, ψ–Hamzah ethics, ψ–Hamzah intellectual property, ψ–Hamzah declaration 2025, Seyed Rasoul Jalali framework, Jalali scientific paradigm, Hamzah biophysics, Hamzah computational biology, Hamzah resilience, Hamzah immunodynamics, Hamzah adaptive fractals, Hamzah stochastic immunity, Hamzah pandemic preparedness, Hamzah biomedical revolution.
• Perinatal Complications (Asphyxia) Vaccine and Drug Development via the ψ–Hamzah Model.
  All Articles are Available: Orcid ID: https://orcid.org/my-orcid?orcid=0009-0009-3175-8563 Science Open ID: https://www.scienceopen.com/user/2c98a8bc-b8bb-49b3-9c91-2f2986a7e16e Safe Creative register the work titled "The Theory of Intelligent Evolution, the H…
  datacite JALALI, SEYED RASOUL 2025 置信度 0.66 ψ–Hamzah, Hamzah Equation, Hamzah Model, Hamzah Vaccine, Hamzah Drug, neonatal asphyxia, perinatal asphyxia, birth complications, neonatal hypoxia, neonatal hypoxaemia, oxidative stress, neonatal mortality, neonatal morbidity, oxygen deprivation, neuronal survival, cardiomyocyte survival, mitochondrial cascade, hypoxic injury, metabolic acidosis, neonatal emergency, neonatal intensive care, oxygen therapy, cerebral protection, cardiac protection, neuroprotection, cardioprotection, hypoxic ischaemia, neonatal medicine, paediatrics, clinical neonatology, newborn survival, neonatal inflammation, cytokine cascade, apoptotic signalling, necrotic signalling, fractal derivative, fractional calculus, complex path integral, fractal pharmacodynamics, fractional pharmacokinetics, PK/PD modelling, advanced PK modelling, advanced PD modelling, nonlinear pharmacology, nonlinear biology, nonlinear systems, stochastic modelling, chaos theory, biological complexity, fractal systems, biomedical mathematics, biophysical modelling, computational medicine, artificial intelligence in medicine, deep learning biology, predictive modelling, cellular dynamics, molecular dynamics, integrative medicine, translational medicine, personalised medicine, precision pharmacology, neonatal drug delivery, neonatal vaccines, neonatal therapeutics, neurovascular protection, mitochondrial reactivation, angiogenesis stimulation, VEGF modulation, HIF-1α stabilisation, protein engineering, peptide engineering, nanomedicine, nanotechnology vaccine, nanotechnology drug, liposomal drug delivery, nanocarrier, PEGylation, PLGA nanoparticle, nanoparticle vaccine, nanoparticle drug, lipid nanoparticles, protein nanoparticle, peptide nanoparticle, drug encapsulation, antigen encapsulation, controlled release, sustained release, drug delivery system, microfluidics, organ-on-a-chip, neonatal simulation, neonatal model, in vitro modelling, in silico modelling, mathematical biology, cellular fractals, mitochondrial fractals, oxygen dynamics, oxygen kinetics, oxygen saturation, oxygen cascade, oxygen distribution, hypoxia adaptation, hypoxia modelling, neonatal brain, neonatal heart, neonatal physiology, neonatal pathology, neonatal pharmacology, neonatal protection, oxygen diffusion, fractal diffusion, diffusion equation, fractional diffusion, stochastic diffusion, Laplace transform, Hamzah transform, spectral analysis, Fourier analysis, wavelet analysis, fractal response, fractal oscillations, cellular fractal response, complex oscillations, fractal immunology, fractal metabolism, nonlinear metabolism, cellular chaos, mitochondrial chaos, drug resistance, genetic mutations, epigenetic regulation, neonatal genetics, neonatal epigenetics, RNA vaccines, mRNA vaccines, DNA vaccines, peptide vaccines, recombinant vaccines, nanoparticle vaccines, immune activation, immune priming, immune resilience, humoral immunity, cellular immunity, T-cell activation, B-cell activation, antibody generation, cytokine signalling, dendritic cell activation, macrophage activation, immune modulation, immunoengineering, vaccine immunology, drug immunology, anti-inflammatory signalling, pro-inflammatory signalling, inflammation control, oxidative damage, ROS inhibition, antioxidant therapy, N-acetyl cysteine, mitochondrial antioxidants, antioxidant peptides, PEG antioxidants, ROS scavenging, mitochondrial repair, neuronal regeneration, cardiac regeneration, synaptic repair, neurovascular coupling, angiogenesis, vascular repair, cerebral perfusion, cardiac perfusion, haemodynamics, neonatal circulation, foetal circulation, placental circulation, transition birth, hypoxic-ischemic encephalopathy, neonatal stroke, perinatal stroke, neonatal seizures, perinatal epilepsy, brain injury prevention, brain tissue protection, cardiomyopathy prevention, perinatal cardiac arrest, sudden infant collapse, neonatal interventions, neonatal therapies, neonatal resuscitation, neonatal protocols, neonatal intensive medicine, neonatal care units, global neonatal health, WHO neonatal strategy, UNICEF neonatal strategy, global vaccine policy, global drug policy, intellectual property, Berne Convention, WIPO patent, pharmacological patent, vaccine patent, nanomedicine patent, IP protection, biomedical innovation, translational science, clinical trials, Phase I trials, Phase II trials, Phase III trials, Phase IV trials, neonatal clinical trial, neonatal ethics, neonatal safety, biomedical ethics, neonatal regulations, GMP standards, cleanroom standards, ISO 5 cleanroom, ISO 7 cleanroom, HEPA filter, controlled temperature, controlled humidity, lyophilisation, freeze-drying stability, protein stability, nanoparticle stability, vaccine stability, drug stability, advanced stability testing, accelerated stability testing, quality control, QC analysis, DLS analysis, zeta potential analysis, HPLC analysis, qPCR testing, ELISA testing, immunoassay testing, cytotoxicity testing, MTT assay, in vitro testing, in vivo testing, computational testing, simulation validation, scenario modelling, stress testing, reproducibility testing, clinical reproducibility, statistical reproducibility, extreme scenarios, 100×100 scenarios, global simulation, trillion scenarios, computational robustness, algorithmic robustness, high-performance computing, biomedical AI, medical AI, AI drug discovery, AI vaccine discovery, AI therapeutics, machine learning biology, quantum biology, quantum pharmacology, integrative fractals, fractal pharmacology, fractal biology, complex biology, systemic modelling, cross-scale modelling, multi-scale modelling, organ-level modelling, cellular-level modelling, subcellular modelling, genomic modelling, proteomic modelling, metabolomic modelling, systems biology, omics biology, computational immunology, computational pharmacology, advanced therapeutics, regenerative medicine, advanced biotechnology, futuristic medicine, neonatal rescue therapy, neonatal regenerative therapy, crisis medicine, extreme scenario medicine, neonatal future medicine, neonatal advanced care, global neonatal medicine, universal neonatal protocol, neonatal anti-asphyxia vaccine, neonatal anti-asphyxia drug, ψ–Hamzah vaccine, ψ–Hamzah drug, ψ–Hamzah medicine, ψ–Hamzah therapy, ψ–Hamzah model validation, ψ–Hamzah universal application, ψ–Hamzah genetic adaptation, ψ–Hamzah resistance modelling, ψ–Hamzah advanced pharmacology, ψ–Hamzah computational pipeline, ψ–Hamzah simulation pipeline, ψ–Hamzah efficacy 99.99%, ψ–Hamzah safety 0%, ψ–Hamzah perfection model, ψ–Hamzah world-class science, ψ–Hamzah intellectual property, ψ–Hamzah clinical translation, ψ–Hamzah neonatal survival, ψ–Hamzah excellence, ψ–Hamzah biomedical architecture, ψ–Hamzah ultimate validation, ψ–Hamzah paradigm shift, ψ–Hamzah scientific revolution.
• Perinatal Complications (Asphyxia) Vaccine and Drug Development via the ψ–Hamzah Model.
  All Articles are Available: Orcid ID: https://orcid.org/my-orcid?orcid=0009-0009-3175-8563 Science Open ID: https://www.scienceopen.com/user/2c98a8bc-b8bb-49b3-9c91-2f2986a7e16e Safe Creative register the work titled "The Theory of Intelligent Evolution, the H…
  datacite JALALI, SEYED RASOUL 2025 置信度 0.66 ψ–Hamzah, Hamzah Equation, Hamzah Model, Hamzah Vaccine, Hamzah Drug, neonatal asphyxia, perinatal asphyxia, birth complications, neonatal hypoxia, neonatal hypoxaemia, oxidative stress, neonatal mortality, neonatal morbidity, oxygen deprivation, neuronal survival, cardiomyocyte survival, mitochondrial cascade, hypoxic injury, metabolic acidosis, neonatal emergency, neonatal intensive care, oxygen therapy, cerebral protection, cardiac protection, neuroprotection, cardioprotection, hypoxic ischaemia, neonatal medicine, paediatrics, clinical neonatology, newborn survival, neonatal inflammation, cytokine cascade, apoptotic signalling, necrotic signalling, fractal derivative, fractional calculus, complex path integral, fractal pharmacodynamics, fractional pharmacokinetics, PK/PD modelling, advanced PK modelling, advanced PD modelling, nonlinear pharmacology, nonlinear biology, nonlinear systems, stochastic modelling, chaos theory, biological complexity, fractal systems, biomedical mathematics, biophysical modelling, computational medicine, artificial intelligence in medicine, deep learning biology, predictive modelling, cellular dynamics, molecular dynamics, integrative medicine, translational medicine, personalised medicine, precision pharmacology, neonatal drug delivery, neonatal vaccines, neonatal therapeutics, neurovascular protection, mitochondrial reactivation, angiogenesis stimulation, VEGF modulation, HIF-1α stabilisation, protein engineering, peptide engineering, nanomedicine, nanotechnology vaccine, nanotechnology drug, liposomal drug delivery, nanocarrier, PEGylation, PLGA nanoparticle, nanoparticle vaccine, nanoparticle drug, lipid nanoparticles, protein nanoparticle, peptide nanoparticle, drug encapsulation, antigen encapsulation, controlled release, sustained release, drug delivery system, microfluidics, organ-on-a-chip, neonatal simulation, neonatal model, in vitro modelling, in silico modelling, mathematical biology, cellular fractals, mitochondrial fractals, oxygen dynamics, oxygen kinetics, oxygen saturation, oxygen cascade, oxygen distribution, hypoxia adaptation, hypoxia modelling, neonatal brain, neonatal heart, neonatal physiology, neonatal pathology, neonatal pharmacology, neonatal protection, oxygen diffusion, fractal diffusion, diffusion equation, fractional diffusion, stochastic diffusion, Laplace transform, Hamzah transform, spectral analysis, Fourier analysis, wavelet analysis, fractal response, fractal oscillations, cellular fractal response, complex oscillations, fractal immunology, fractal metabolism, nonlinear metabolism, cellular chaos, mitochondrial chaos, drug resistance, genetic mutations, epigenetic regulation, neonatal genetics, neonatal epigenetics, RNA vaccines, mRNA vaccines, DNA vaccines, peptide vaccines, recombinant vaccines, nanoparticle vaccines, immune activation, immune priming, immune resilience, humoral immunity, cellular immunity, T-cell activation, B-cell activation, antibody generation, cytokine signalling, dendritic cell activation, macrophage activation, immune modulation, immunoengineering, vaccine immunology, drug immunology, anti-inflammatory signalling, pro-inflammatory signalling, inflammation control, oxidative damage, ROS inhibition, antioxidant therapy, N-acetyl cysteine, mitochondrial antioxidants, antioxidant peptides, PEG antioxidants, ROS scavenging, mitochondrial repair, neuronal regeneration, cardiac regeneration, synaptic repair, neurovascular coupling, angiogenesis, vascular repair, cerebral perfusion, cardiac perfusion, haemodynamics, neonatal circulation, foetal circulation, placental circulation, transition birth, hypoxic-ischemic encephalopathy, neonatal stroke, perinatal stroke, neonatal seizures, perinatal epilepsy, brain injury prevention, brain tissue protection, cardiomyopathy prevention, perinatal cardiac arrest, sudden infant collapse, neonatal interventions, neonatal therapies, neonatal resuscitation, neonatal protocols, neonatal intensive medicine, neonatal care units, global neonatal health, WHO neonatal strategy, UNICEF neonatal strategy, global vaccine policy, global drug policy, intellectual property, Berne Convention, WIPO patent, pharmacological patent, vaccine patent, nanomedicine patent, IP protection, biomedical innovation, translational science, clinical trials, Phase I trials, Phase II trials, Phase III trials, Phase IV trials, neonatal clinical trial, neonatal ethics, neonatal safety, biomedical ethics, neonatal regulations, GMP standards, cleanroom standards, ISO 5 cleanroom, ISO 7 cleanroom, HEPA filter, controlled temperature, controlled humidity, lyophilisation, freeze-drying stability, protein stability, nanoparticle stability, vaccine stability, drug stability, advanced stability testing, accelerated stability testing, quality control, QC analysis, DLS analysis, zeta potential analysis, HPLC analysis, qPCR testing, ELISA testing, immunoassay testing, cytotoxicity testing, MTT assay, in vitro testing, in vivo testing, computational testing, simulation validation, scenario modelling, stress testing, reproducibility testing, clinical reproducibility, statistical reproducibility, extreme scenarios, 100×100 scenarios, global simulation, trillion scenarios, computational robustness, algorithmic robustness, high-performance computing, biomedical AI, medical AI, AI drug discovery, AI vaccine discovery, AI therapeutics, machine learning biology, quantum biology, quantum pharmacology, integrative fractals, fractal pharmacology, fractal biology, complex biology, systemic modelling, cross-scale modelling, multi-scale modelling, organ-level modelling, cellular-level modelling, subcellular modelling, genomic modelling, proteomic modelling, metabolomic modelling, systems biology, omics biology, computational immunology, computational pharmacology, advanced therapeutics, regenerative medicine, advanced biotechnology, futuristic medicine, neonatal rescue therapy, neonatal regenerative therapy, crisis medicine, extreme scenario medicine, neonatal future medicine, neonatal advanced care, global neonatal medicine, universal neonatal protocol, neonatal anti-asphyxia vaccine, neonatal anti-asphyxia drug, ψ–Hamzah vaccine, ψ–Hamzah drug, ψ–Hamzah medicine, ψ–Hamzah therapy, ψ–Hamzah model validation, ψ–Hamzah universal application, ψ–Hamzah genetic adaptation, ψ–Hamzah resistance modelling, ψ–Hamzah advanced pharmacology, ψ–Hamzah computational pipeline, ψ–Hamzah simulation pipeline, ψ–Hamzah efficacy 99.99%, ψ–Hamzah safety 0%, ψ–Hamzah perfection model, ψ–Hamzah world-class science, ψ–Hamzah intellectual property, ψ–Hamzah clinical translation, ψ–Hamzah neonatal survival, ψ–Hamzah excellence, ψ–Hamzah biomedical architecture, ψ–Hamzah ultimate validation, ψ–Hamzah paradigm shift, ψ–Hamzah scientific revolution.
• Metalation calculator for <i>E. coli</i> strain BW25113 grown in M9 minimal media
  preprints 2025 置信度 0.74
• CTx001 for geographic atrophy: a gene therapy expressing soluble, truncated complement receptor 1 (mini-CR1)
  preprints 2025 置信度 0.74
• Canonical transcription termination mechanisms explain a minority of operons in cyanobacteria
  preprints 2025 置信度 0.74
• Species-specific detection of<i>Schistosoma japonicum</i>using the ‘SNAILS’ DNA-based biosensor
  preprints 2025 置信度 0.74
• Expression of nano-engineered RNA organelles in bacteria
  preprints 2025 置信度 0.74
• A Modular Bioinstructive Platform for Additive-Free, Topography-Driven Stem Cell Differentiation and Patterning
  preprints 2025 置信度 0.74
• Policies to Enhance the Resilience of US Manufacturing
  The COVID-19 pandemic has drawn worldwide attention to the fragility of global value chains for manufactured goods. In the United States, it is prompting a policy discussion about resilience—the ability to adjust in real time to supply chain disruptions while …
  preprints 2020 置信度 0.74
• A Submission to the Senate Select Committee on COVID-19 on the TRIPS Waiver: Intellectual Property, Access to Essential Medicines, and the Coronavirus COVID-19
  preprints 2022 置信度 0.74
• The Pan-Securitization of the Biden Administration’s Biomanufacturing Strategy
  Since assuming office, the Biden administration has emphasized biomanufacturing as a cornerstone of efforts to rejuvenate American manufacturing. This sector has become a globally significant and strategically emerging industry, showcasing substantial growth p…
  crossref Bo Peng, Bei Tang 2025-05-16T06:52:02Z 置信度 0.70
• Synergizing artificial intelligence and operations research for advancements in biomanufacturing
  europepmc Tugce Martagan, Tinglong Dai 2025 置信度 0.80
• Biomanufacturing of Biobased Material Monomers
  crossref Xiwei Tian, Yuanchan Luo, Juefeng Lu, Jiaping Jiang 等 2025-09-27T10:23:25Z 置信度 0.70
• Circular Design and Biomanufacturing
  crossref Kamini Pandey, Madhu Kumari, Alok Prapati, Sonali 等 2025-10-24T17:23:24Z 置信度 0.70
• Synthetic biomanufacturing of plant natural products: technological breakthroughs and industrial transformation
  Plant natural products possess significant application value in medicine, food, and agriculture owing to their diverse biological activities. However, traditional production methods relying on plant extraction face challenges including resource scarcity, low e…
  crossref Jinzhou Lu 2025-07-18T02:51:17Z 置信度 0.70
• Development of a Biochemical &amp; Biomanufacturing Track in the Unit Operations of Chemical Engineering Laboratory Course
  crossref Laila Abu-Lail, Andrew Teixeira 2025-08-21T19:33:06Z 置信度 0.70
• Bioprocess Optimization Strategies
  With the increasing global demand for biopharmaceuticals and industrial biologics, optimizing biomanufacturing processes become imperative. The optimization of bioprocesses aims to maximize the efficiency and yield in biomanufacturing while maintaining cost-ef…
  crossref Deepak Kumar Jha, S. Archana, Zohreh Elyasi 2025-09-30T19:26:24Z 置信度 0.70
• Regional Food Biomanufacturing Innovation Hubs Can Catalyze US Biotechnology and National Security
  Engineering biology and emerging biotechnologies are poised to diversify food production processes and provide sustainable and nutritious foods to consumers. Embracing a regional, food-focused innovation hub network can be a key strategy for advancing US biote…
  crossref Erin Rees Clayton, Curt Chaffin 2025-08-02T20:07:44Z 置信度 0.70
• ENHANCING DATA INTEGRITY AND REGULATORY COMPLIANCE IN BIOMANUFACTURING USING PAS X MANUFACTURING EXECUTION SYSTEM
  Background: Data integrity and regulatory compliance a major issues in biomanufacturing and of specific concern with the rise of ever-more complicated biologics and personalized medicines. The conventional paper-based systems are unable to effectively adhere t…
  crossref Sahana Vasudev, 2025-10-22T15:56:03Z 置信度 0.70
• Beyond photosynthesis: Harnessing heterotrophic CO2 fixation in Euglena gracilis for next-generation carbon capture and circular biomanufacturing
  crossref Sahutchai Inwongwan 2025-11-26T16:18:28Z 置信度 0.70
• Chemically inducible chromosome evolution of Corynebacterium glutamicum for producing 4-hydroxyisoleucine
  crossref Weiqing Chen, Rui Chen, Feng Shi 2025-03-28T10:21:32Z 置信度 0.70
• Molecular docking analysis of laccase mediated bioremediation of pharmaceutical compounds from wastewater
  crossref Aman Choudhary, Archana Tiwari, Hina Bansal 2025-01-06T14:34:59Z 置信度 0.70
• Evolutionary engineering of Pichia pastoris for α-farnesene biosynthesis from methanol
  crossref Ziyun Gu, Tiantian Chai, Xiulai Chen 2025-05-19T02:09:55Z 置信度 0.70
• Engineering the antioxidant activity of Candida glabrata by enhancing malate biosynthesis
  crossref Pan Zhu, Jiaying Chen, Yufei Li, Xinyi Sun 2025-03-28T10:19:19Z 置信度 0.70
• Alpha-ketoacid decarboxylases: Diversity, structures, reaction mechanisms, and applications for biomanufacturing of platform chemicals and fuels
  crossref Khanh Ha, Seunghyun Ryu, Cong T. Trinh 2025-02-13T16:43:20Z 置信度 0.70
• Understanding phage resistance to enhance biomanufacturing bacteria
  crossref Catherine Mageeney, Benjamin Diaz, James Jaryenneh 2026-02-18T20:24:45Z 置信度 0.70
• Physiology-informed use of Cupriavidus necator in biomanufacturing: a review of advances and challenges
  Abstract Biomanufacturing offers a potentially sustainable alternative to deriving chemicals from fossil fuels. However, traditional biomanufacturing, which uses sugars as feedstocks, competes with food production and yields unfavourable land use changes, so m…
  crossref Michael Weldon, Christian Euler 2025-01-22T12:06:43Z 置信度 0.70
• Development of fungal cell factories for efficient green biomanufacturing: novel regulators and improving robustness
  crossref X Zhao, D Zeng, X Li, B Yuan 等 2025-07-07T19:26:50Z 置信度 0.70
• Stipulations of cell and gene therapy and the ties to biomanufacturing
  Abstract Cell and gene therapy (CGT) products are emerging and innovative biopharmaceuticals that hold promise for treating diseases that are otherwise beyond the scope of conventional medicines. The evolution of CGT from a research idea to a promising therape…
  crossref Justin Allisha, Juthika Das, Thomas Dunnigan, Susan T. Sharfstein 等 2025-01-23T07:59:32Z 置信度 0.70
• Transcriptional regulator-based biosensors for biomanufacturing in Corynebacterium glutamicum
  crossref Jie Liu, Wei-Guo Zhang, Zhi-Ming Rao 2025-04-06T22:12:30Z 置信度 0.70
• Progress in one-carbon metabolism: Clostridium in green biomanufacturing
  crossref Zhuoheng Wu, Ming Ma, Bowen Zeng, Kai Wang 等 2025-06-16T23:18:38Z 置信度 0.70
• Microbial production and applications of glucose oxidase
  crossref Mehwish Sarfaraz, Dalia Sukmawati, Hafiz Abdullah Shakir, Muhammad Khan 等 2025-03-11T01:28:24Z 置信度 0.70
• Rewiring photosynthetic carbon flow: Engineered cyanobacterial factories for sustainable carbohydrate production and carbon-negative biomanufacturing
  europepmc Xinyi Bai, Guangbao Zhang, Libo Xu, Kang Li 等 2025 置信度 0.80
• Synthetic Genome Design for Biomanufacturing: Integrated Modeling with CRISPR Tools, Python, and Geneious
  Abstract: This study presents a comprehensive approach to synthetic genome design aimed at enhancing microbial biomanufacturing performance. The framework integrates CRISPR-based gene editing (using CHOPCHOP), sequence assembly with Geneious, and metabolic pat…
  crossref Murali Krishna Pasupuleti 2025-05-19T23:23:41Z 置信度 0.70
• Way Forward for Biomanufacturing and Biotechnology in Europe
  To restrict global warming to a maximum of 1.5 °C, greenhouse gas emissions need to be reduced to ‘net zero’ by 2050. The transition from the current, largely fossil-based global economy towards a circular, nowaste (bio-) economy based on renewable raw materia…
  europepmc Ulla Létinois, Steven Crump, Bastian Zerrer, Michael Hans 等 2025 置信度 0.80
• Pre-structuring Product Development Challenges in the Context of Advanced Biomanufacturing
  crossref Manuel Sonnenberg, Robert Miehe, Steffen Kiemel, Thomas Bauernhansl 2025-08-29T11:43:06Z 置信度 0.70
• Continuous monitoring of dsDNA fragments for biomanufacturing: Sensor development and feasibility study
  europepmc Selina A.J. Janssen, Arthur M. de Jong, Menno W.J. Prins 2025 置信度 0.80
• Agro-industrial waste management: solid-state fermentation for biomass conversion and valorisation to value-added products
  crossref Moinal Hoque, K. T. Ramya Devi 2025-05-16T02:47:27Z 置信度 0.70
• The Global Capacity Squeeze in Biomanufacturing
  crossref Pierre Catignol 2025-09-09T17:06:07Z 置信度 0.70
• Coronavirus Replication: Genomes, Subgenomic RNAs, and Defective Viral Genomes
  With the emergence of the SARS-CoV-2 pandemic the process of coronavirus replication has been under increasing scrutiny. During the replication of their genomic RNA, coronaviruses produce a range of other RNAs in addition to the negative-sense replicative inte…
  crossref Rory Williams, Jack Hales, William Collier, Phillip Gould 2025-05-29T03:30:19Z 置信度 0.70
• Engineering of farnesyl pyrophosphate hydrolase for farnesol production in Serratia marcescens
  crossref Xia Chen, Di Liu, Long Wang, Yao Lu 等 2025-03-03T02:50:46Z 置信度 0.70
• Integrative network-level rewiring of photosynthetic metabolism boosts phycocyanin biosynthesis in cyanobacterial chassis.
  europepmc 2026 置信度 0.80
• Harnessing yeasts for sustainable methanol valorization: Metabolic and fermentation engineering strategies.
  europepmc 2026 置信度 0.80
• Sequence cluster and distal-site engineering of Fdc for efficient isobutene biosynthesis.
  europepmc 2026 置信度 0.80
• Correction: Zou et al. Two-Component MprAB System Regulates the Expression of Genes Involved in Cell Envelope Biosynthesis in &lt;i&gt;Corynebacterium glutamicum&lt;/i&gt;. &lt;i&gt;Microorganisms&lt;/i&gt; 2025, &lt;i&gt;13&lt;/i&gt;, 1120.
  europepmc 2026 置信度 0.80
• Advanced therapy medicinal products in Saudi Arabia: Regulation and development.
  europepmc 2026 置信度 0.80
• Genome-wide hypermutation-engineered Synechocystis sp. PCC 6803 reveals membrane-mediated triclosan resistance.
  europepmc 2026 置信度 0.80
• Label-Free Near-Infrared Image Cytometry for Chlorophyll Quantification and Carotenoid Prediction with Multiparametric Biophysicochemical Profiling.
  europepmc 2026 置信度 0.80
• [Multi-technology integration and feedstock innovation drive biomanufacturing development].
  europepmc 2025 置信度 0.80
• Corrigendum to "Ganoderma lucidum dietary fiber and lactobacillus fermentum CECT5716 alleviate constipation via regulation of gut barrier and microbiota" [Int. J. Biol. Macromol. 333 (2025) 149010].
  europepmc 2026 置信度 0.80
• [Reform and practice of innovative bioengineering undergraduate talent cultivation model driven by demand and multiple dimensions].
  europepmc 2026 置信度 0.80
• Spatiotemporal Control of Liquid-Liquid Phase Separation for Advanced Biomanufacturing.
  europepmc Yingying Li, Can Zeng, Xiaoye Lyu, Wei Tan 等 2025 置信度 0.80
• CRISPR/Cas9-mediated gene targeting at BBM2 locus demonstrates HDR-assisted precise knock-in in banana cv. Grand Naine.
  europepmc 2025 置信度 0.80
• Insights into polyolefin oligomer stress regulation of microbial communities and degradation mechanisms of polyethylene.
  europepmc 2025 置信度 0.80
• Effects of oligosaccharides in synergy with Enterococcus hirae F42 derived from infant intestines on the milk fermentation process and quality.
  europepmc 2026 置信度 0.80
• [Yeast biotechnology and green biomanufacturing: current status and future prospects].
  europepmc 2025 置信度 0.80
• Isolation of bacteria that catabolize abiotically synthesized tetroses via the formose reaction.
  europepmc 2025 置信度 0.80
• Distributed Biomanufacturing Facilities of the Future.
  europepmc 2025 置信度 0.80
• Recent Advances in Butyrate Production from Food Waste Fermentation: Key Functional Microbes, Habitat Engineering, and Future Challenges.
  europepmc 2026 置信度 0.80
• Aerobic granular sludge: Formation mechanism, accelerating granulation strategies, and emerging applications.
  europepmc 2025 置信度 0.80
• Importance rapid initial decline in oxidation-reduction potential, followed by an increase in extracellular electron transport activities, for the rapid onset of indigo reduction.
  europepmc 2025 置信度 0.80
• Metabolic engineering of Vibrio natriegens for the production of N-acetylglucosamine.
  europepmc 2025 置信度 0.80